Author Archives: Patrick Gurgel

Development of Affinity Chromatography Adsorbents for Bioseparations

Affinity chromatography has a long history of use in biopharmaceutical manufacturing and is a powerful tool in making industrial processes more efficient by reducing the number of steps required to achieve the desired target purity and yield of a final product. It is common, however, for teams to consider affinity chromatography once all other options have been considered, evaluated, and discarded. Such an approach usually translates into a need to develop affinity adsorbents for new targets quickly, efficiently, and economically.…

Removal of Isoagglutinins from IVIG and Plasma Using Affinity Chromatography

Antibody-mediated haemolysis is a hard-to-predict phenomenon with potentially severe consequences. It is mediated by naturally-occurring anti-A and anti-B immunoglobulin isoagglutinins, which are present in plasma, blood, and several derived products, including IVIG produced by plasma fractionation. Prometic Bioseparations have developed an affinity chromatography resin for the removal of isoagglutinins from plasma and plasma derived products, such as IVIG. The resins, IsoClear A and IsoClear B, can clear isoagglutinins from a titre of 1/32 down to negative agglutination using a load…

Multi-Mode Mimetic Ligand™ Library – A Rapid Screening Toolbox for Target Protein Purification

Small synthetic ligands have established themselves as an essential component of modern downstream processes, both as specific ligands for product capture or the targeted removal of impurities and more generally for product polishing applications. Historically, the identification of a specific ligand for a target protein has required the engagement of specialist companies. Whilst this approach can be very successful, such studies often require some time to set-up and perform (i.e. from ligand discovery, to adsorbent/process development and finally manufacture) and…